PIVAC 2018 was held in Oslo, co-organized by the department of Cell Therpay. The conference permitted to share new advance in the field of vaccination and future prospects for immunotherapy.
T-cell receptor therapy (TCR) against melanoma -immunotherapy for the future?
Scand J Immunol, e12927 (in press)
A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation
Cancers (Basel), 12 (6)
A catalogue of Ovarian Cancer targets for CAR therapy
Scand J Immunol, e12917 (in press)